Latest News – Page 35 – Safe Biologics

ASBM Presents at University of the Sciences in Philadelphia

September 15, 2016

On September 15th, 2016, ASBM held an educational forum at the University of the Sciences in Philadelphia (USciences). The program drew 50 attendees comprised of pharmacists, faculty members, pharmacy students. The program began with an introduction to biosimilars from USciences Associate Professor of Pharmaceutical Sciences Dr. Zhiyu Li. Dr. Li is Director of Undergraduate Pharmacology/Toxicology Program, where he […]

A Picture is worth a thousand words…

September 15, 2016

A Picture is worth a thousand words… Why Memorable Names are preferred by Pharmacists by Philip Schneider, MS FASHP Associate Dean, University of Arizona College of Pharmacy ASBM Advisory Board Chair Yesterday, I was in Philadelphia with a group of about 50 pharmacy students and faculty speaking about biosimilars and the role they do play and […]

A Picture is worth a thousand words…

September 15, 2016

A Picture is worth a thousand words… Why Memorable Names are preferred by Pharmacists by Philip Schneider, MS FASHP Associate Dean, University of Arizona College of Pharmacy ASBM Advisory Board Chair Yesterday, I was in Philadelphia with a group of about 50 pharmacy students and faculty speaking about biosimilars and the role they do play and […]

ASBM and MD State Medical Society Host Biosimilars Forum in Baltimore

July 25, 2016

On Friday, July 22nd, The Alliance for Safe Biologic Medicines and MedChi, the Maryland State Medical Society co-hosted a forum entitled “Biosimilars: New Choices, New Challenges”. The event was attended by more than 45 physicians, legislators, patient advocates, healthcare workers, and others. MedChi’s CEO, Gene Ransom III began the forum with a discussion of the importance of biosimilars […]

ASBM and MD State Medical Society Host Biosimilars Forum in Baltimore

July 25, 2016

On Friday, July 22nd, The Alliance for Safe Biologic Medicines and MedChi, the Maryland State Medical Society co-hosted a forum entitled “Biosimilars: New Choices, New Challenges”. The event was attended by more than 45 physicians, legislators, patient advocates, healthcare workers, and others. MedChi’s CEO, Gene Ransom III began the forum with a discussion of the importance of biosimilars […]

VIDEO: Autoimmune Patient Discusses Concerns with Non-Medical Switching

July 8, 2016

In this video, patient advocate Kathleen Arntsen, President and CEO of the Lupus and Allied Diseases Association (LADA) and an autoimmune patient herself, discusses the power of advocacy and her concerns with Non-Medical Switching (NMS). NMS is the switching of a patient from one treatment to another, typically by a third party such as a Pharmacy Benefit Manager (PBM) […]

VIDEO: Autoimmune Patient Discusses Concerns with Non-Medical Switching

July 8, 2016

In this video, patient advocate Kathleen Arntsen, President and CEO of the Lupus and Allied Diseases Association (LADA) and an autoimmune patient herself, discusses the power of advocacy and her concerns with Non-Medical Switching (NMS). NMS is the switching of a patient from one treatment to another, typically by a third party such as a Pharmacy Benefit Manager (PBM) […]

ASBM Promotes High Approval Standards, Memorable Names at DIA 2016

July 6, 2016

ASBM was an exhibitor during the 52nd Annual meeting of the Drug Information Association (DIA) held June 26th-30th in Philadelphia. ASBM members and staff discussed biosimilars policy with attendees, including the need for the FDA to maintain high standards for safety and efficacy when approving biosimilars. More than 65 attendees, including clinical researchers, physicians, pharmacists, […]

ASBM Presents at Latin American Forum on Biosimilars

July 6, 2016

On June 29th, ASBM Chairman Harry L. Gewanter, MD and ASBM Steering Committee Member Andrew Spiegel, Executive Director of the Global Colon Cancer Association, gave presentations at the 6th Latin American Forum on Biosimilars, held in Brasília, Brazil. The event was also the 7th Brazilian Forum on Biosimilars. The event was attended by more than 500 […]

ASBM Presents at Latin American Forum on Biosimilars

July 6, 2016

On June 29th, ASBM Chairman Harry L. Gewanter, MD and ASBM Steering Committee Member Andrew Spiegel, Executive Director of the Global Colon Cancer Association, gave presentations at the 6th Latin American Forum on Biosimilars, held in Brasília, Brazil. The event was also the 7th Brazilian Forum on Biosimilars. The event was attended by more than 500 […]